Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study

Neurology

Volumn 58, Issue 11, 2002, Pages 1629-1634

  Pfeifer, L A ^a   White, L R ^b   Ross, G W ^c   Petrovitch, H ^b   Launer, L J ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b Center for Health Research   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

AGED; ALLELE; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEOCORTEX; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SENILE PLAQUE; VASCULAR AMYLOIDOSIS;

EID: 0037062566     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.58.11.1629     Document Type: Article

References (37)

1. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, part XV
2. Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan
3. Cerebral amyloid angiopathy
4. Neuropathologic features and grading of Alzheimer-related and sporadic CAA
5. Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston criteria
6. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Introduction
7. Prevalence of dementia in older Japanese-American men living in Hawaii: The Honolulu-Asia Aging Study
8. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
9. The Cognitive Abilities Screening Instrument (CASI): A practical test for cross-cultural epidemiological studies of dementia
10. The clinical assessment of dementia in the aged: A dementia screening scale for psychogeriatric patients
11. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician
12. The Modified Mini-Mental State (3MS) examination
13. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): Socio-demographic correlates, reliability, validity and some norms
14. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part I: Clinical and neuropsychological assessment of Alzheimer's disease
15. Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease
16. Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's Disease Diagnostic and Treatment Centers
17. Kunitz protease inhibitor-containing amyloid beta protein precursor activity in Alzheimer's disease
18. Cerebral amyloid angiopathy: Incidence and complications in the aging brain II. The distribution of vascular amyloid changes
19. Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study
20. Histopathologic methods and color atlas of special stains and tissue artifacts
21. Microscope field size and the neuropathologic criteria for Alzheimer's disease
22. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part II. Standardization of the neuropathologic assessment of Alzheimer's disease
23. Cerebral amyloid angiopathy in dementia and old age
24. Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study
25. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease
26. Identification of normal and pathological aging in prospectively studies nondemented elderly humans
27. Cerebral amyloid angiopathy in the aged
28. Dementia in cerebral amyloid angiopathy: A clinicopathological study
29. Cerebral amyloid angiopathy: A significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly
30. Progression of cerebral amyloid angiopathy: Accumulation of amyloid-β40 in affected vessels
31. Cerebrovascular amyloidosis: Experimental analysis in vitro and in vivo
32. Critically attained threshold of cerebral hypoperfusion: The CATCH hypothesis of Alzheimer's pathogenesis
33. Beta-amyloid-mediated vasoactivity and vascular endothelial damage
34. Structural basis of the cognitive alterations in Alzheimer's disease
35. Cerebrovascular disease